Aurora Cannabis Inc Forecasted to Earn FY2020 Earnings of ($0.12) Per Share (NYSE:ACB)

Share on StockTwits

Aurora Cannabis Inc (NYSE:ACB) – Cantor Fitzgerald issued their FY2020 earnings per share estimates for Aurora Cannabis in a research note issued on Tuesday, November 5th. Cantor Fitzgerald analyst P. Zuanic expects that the company will post earnings of ($0.12) per share for the year. Cantor Fitzgerald currently has a “Neutral” rating and a $5.10 price target on the stock.

A number of other research firms have also weighed in on ACB. CIBC began coverage on Aurora Cannabis in a research note on Tuesday, September 24th. They set a “neutral” rating and a $7.00 price objective on the stock. ValuEngine raised Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Wednesday, August 21st. Stifel Nicolaus reissued a “sell” rating and set a $5.00 price objective (down previously from $7.00) on shares of Aurora Cannabis in a research note on Thursday, September 12th. Compass Point set a $8.00 price objective on Aurora Cannabis and gave the stock a “hold” rating in a research note on Thursday, September 12th. Finally, Bank of America lowered Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 price objective on the stock. in a research note on Thursday, July 18th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the company’s stock. Aurora Cannabis currently has a consensus rating of “Hold” and a consensus price target of $7.43.

NYSE ACB opened at $3.81 on Friday. The stock’s fifty day moving average is $4.04 and its two-hundred day moving average is $6.41. The firm has a market capitalization of $3.92 billion, a P/E ratio of -17.32 and a beta of 2.30. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.14 and a current ratio of 1.52. Aurora Cannabis has a fifty-two week low of $3.40 and a fifty-two week high of $10.32.

Several institutional investors have recently made changes to their positions in the company. First Allied Advisory Services Inc. lifted its stake in shares of Aurora Cannabis by 17.1% in the 3rd quarter. First Allied Advisory Services Inc. now owns 41,562 shares of the company’s stock valued at $181,000 after purchasing an additional 6,058 shares during the last quarter. Cetera Advisors LLC lifted its stake in shares of Aurora Cannabis by 5.4% in the 3rd quarter. Cetera Advisors LLC now owns 76,092 shares of the company’s stock valued at $336,000 after purchasing an additional 3,899 shares during the last quarter. Cetera Advisor Networks LLC lifted its stake in shares of Aurora Cannabis by 13.8% in the 3rd quarter. Cetera Advisor Networks LLC now owns 65,157 shares of the company’s stock valued at $281,000 after purchasing an additional 7,890 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of Aurora Cannabis by 613.0% in the 3rd quarter. Tower Research Capital LLC TRC now owns 20,678 shares of the company’s stock valued at $91,000 after purchasing an additional 17,778 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Aurora Cannabis in the 3rd quarter valued at $439,000. 8.84% of the stock is currently owned by institutional investors and hedge funds.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Article: Should You Consider an Index Fund?

Earnings History and Estimates for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.